Related references
Note: Only part of the references are listed.Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: Role of glucose as adjuvant
M. Dubois et al.
NEUROPHARMACOLOGY (2014)
Single Rapamycin Administration Induces Prolonged Downward Shift in Defended Body Weight in Rats
Mark Hebert et al.
PLOS ONE (2014)
Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
Dipti K. Pawaskar et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Hypothalamic signaling in anorexia induced by indispensable amino acid deficiency
Xinxia Zhu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin
Luis Martins et al.
PLOS ONE (2012)
Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity
Joanna E. Fardell et al.
PSYCHOPHARMACOLOGY (2012)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Giuseppe Di Lorenzo et al.
EUROPEAN UROLOGY (2011)
Akt/mammalian target of rapamycin signaling pathway regulates neurite outgrowth in cerebellar granule neurons stimulated by methylcobalamin
Kiyoshi Okada et al.
NEUROSCIENCE LETTERS (2011)
Chronic Hypoxia Impairs Murine Hippocampal Development and Depletes the Postnatal Progenitor Pool by Attenuating Mammalian Target of Rapamycin Signaling
Lakshmi Raman et al.
PEDIATRIC RESEARCH (2011)
Cognitive dysfunction and cancer: which consequences in terms of disease management?
Florence Joly et al.
PSYCHO-ONCOLOGY (2011)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
Robert J. Motzer et al.
CANCER (2010)
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Vanessa P. Houde et al.
DIABETES (2010)
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease
Jonathan H. Fox et al.
MOLECULAR NEURODEGENERATION (2010)
Regulation of neural stem/progenitor cell maintenance by PI3K and mTOR
Atsushi Sato et al.
NEUROSCIENCE LETTERS (2010)
Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies
James M. G. Larkin et al.
ONCOLOGIST (2010)
Regulation of gastric hormones by systemic rapamycin
Geyang Xu et al.
PEPTIDES (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
Critical roles for the TSC-mTOR pathway in β-cell function
Hiroyuki Mori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
An Emerging Role of mTOR in Lipid Biosynthesis
Mathieu Laplante et al.
CURRENT BIOLOGY (2009)
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Targeting the mTOR Signaling Network for Cancer Therapy
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy
Ling-Hui Zeng et al.
JOURNAL OF NEUROSCIENCE (2009)
Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination
S. Priyadarshini Narayanan et al.
JOURNAL OF NEUROSCIENCE (2009)
Role of the melanin-concentrating hormone neuropeptide in sleep regulation
Christelle Peyron et al.
PEPTIDES (2009)
Medullary pathways mediating the parasubthalamic nucleus depressor response
John Ciriello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat
Riejanne Seigers et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
R. Bianco et al.
BRITISH JOURNAL OF CANCER (2008)
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function
Amelia Barilli et al.
CARDIOVASCULAR RESEARCH (2008)
Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer
Philipp C. Manegold et al.
CLINICAL CANCER RESEARCH (2008)
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data
Chiaki Tanaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: A phase I tumor pharmacodynamic study in patients with advanced solid tumors
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation
Jacqueline Blundell et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
On the participation of mTOR in recognition memory
Jociane C. Myskiw et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
A NOVEL ELECTROPHYSIOLOGICAL MODEL OF CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENTS IN MICE
M. J. Gandal et al.
NEUROSCIENCE (2008)
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Kevin Kyungsuk Park et al.
SCIENCE (2008)
Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases
Lianne C. Krab et al.
TRENDS IN GENETICS (2008)
The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2
X. Yang et al.
JOURNAL OF ANIMAL SCIENCE (2007)
Reversible posterior Leukoencephalopathy syndrome induced by sunitinib
German Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2007)
IQGAP1 regulates adult neural progenitors in vivo and vascular endothelial growth factor-triggered neural progenitor migration in vitro
Laurent Balenci et al.
JOURNAL OF NEUROSCIENCE (2007)
RAD001 (everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
Seiji Mabuchi et al.
CANCER RESEARCH (2007)
Targeting mammalian target of rapamycin (mTOR) for health and diseases
Chi Kwan Tsang et al.
DRUG DISCOVERY TODAY (2007)
mTOR signaling in the hippocampus is necessary for memory formation
Pedro Bekinschtein et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2007)
Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons
Ryan G. Parsons et al.
JOURNAL OF NEUROSCIENCE (2006)
Central nervous system control of food intake and body weight
G. J. Morton et al.
NATURE (2006)
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies
Karen W. L. Yee et al.
CLINICAL CANCER RESEARCH (2006)
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice
Gordon Winocur et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-mammalian target of rapamycin pathway
Pramod K. Dash et al.
JOURNAL OF NEUROSCIENCE (2006)
Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat
Jennifer M. Horwood et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Hypothalamic mTOR signaling regulates food intake
D Cota et al.
SCIENCE (2006)
Memory-dependent c-Fos expression in the nucleus accumbens and extended amygdala following the expression of a conditioned taste aversive in the rat
Y. Yasoshima et al.
NEUROSCIENCE (2006)
Corticostriatal-hypothalamic circuitry and food motivation: Integration of energy, action and reward
AE Kelley et al.
PHYSIOLOGY & BEHAVIOR (2005)
Alternative pathways for catecholamine action in oral motor control
MB Mascaro et al.
NEUROSCIENCE LETTERS (2005)
Effects of systemic lupus erythematosus on spatial cognition and cerebral regional metabolic reactivity in BxSB lupus-prone mice
A Arabo et al.
NEUROSCIENCE (2005)
Axonal projections from the parasubthalamic nucleus
M Goto et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells
A Boulay et al.
CANCER RESEARCH (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Overlapping distributions of orexin/hypocretin- and dopamine-β-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress
BA Baldo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory
W Tischmeyer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Oral everolimus inhibits in-stent neointimal growth
A Farb et al.
CIRCULATION (2002)
A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus
SJ Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Rac regulates vascular endothelial growth factor stimulated motility
N Soga et al.
CELL COMMUNICATION AND ADHESION (2001)
Share Paper
